Post-approval studies (Phase 4)UnknownNCT01936285What this trial is testingColchicine in ST-elevation Myocardial InfarctionWho this might be right forAcute Myocardial Infarction G.Gennimatas General Hospital 150
Post-approval studies (Phase 4)Study completedNCT01381185What this trial is testingREsistance to Aspirin and Clopidogrel in acuTe Myocardial InfarctionWho this might be right forAcute Myocardial Infarction University Hospital Ostrava 154
Not applicableStudy completedNCT01144819What this trial is testingPlatelet Inhibition in the Acute Phase of STEMIWho this might be right forAcute Myocardial InfarctionAntiplatelet TherapyST-segment Elevation Myocardial Infarction (STEMI) University of Aarhus 46
Testing effectiveness (Phase 2)WithdrawnNCT00691834What this trial is testingSafety and Efficacy on Cell-based Therapy in Patients With Recent Large Acute Myocardial InfarctionWho this might be right forAcute Myocardial InfarctionHeart Failure Duke University
Large-scale testing (Phase 3)Study completedNCT02181998What this trial is testingA Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital SettingWho this might be right forMyocardial Infarction Boehringer Ingelheim 1,606
Large-scale testing (Phase 3)Study completedNCT04837001What this trial is testingEvaluation in STEMI Patients Using FDY-5301Who this might be right forAcute Myocardial InfarctionSTEMIPercutaneous Coronary Revascularization Faraday Pharmaceuticals, Inc. 2,351
Testing effectiveness (Phase 2)Looking for participantsNCT06147986What this trial is testingEvaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) PatientsWho this might be right forST Elevation Myocardial Infarction Ever Supreme Bio Technology Co., Ltd. 41
Testing effectiveness (Phase 2)Ended earlyNCT04912141What this trial is testingPrevention of Acute Kidney Injury in Patients With NSTEMIWho this might be right forNon-ST Elevation Myocardial Infarction (NSTEMI) Pharming Technologies B.V. 29
Testing effectiveness (Phase 2)Study completedNCT05350969What this trial is testingStudy to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial InfarctionWho this might be right forMyocardial Infarction, AcuteHeart Failure, Left Sided Cardior Pharmaceuticals GmbH 294
Testing effectiveness (Phase 2)UnknownNCT05531955What this trial is testingPirfenidone Treat Myocardial Fibrosis After Acute Myocardial InfarctionWho this might be right forMyocardial Fibrosis Shanghai Zhongshan Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00877903What this trial is testingProchymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)Who this might be right forMyocardial Infarction Mesoblast, Inc. 220
Testing effectiveness (Phase 2)Looking for participantsNCT06792643What this trial is testingCangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMOWho this might be right forCardiogenic ShockExtracorporeal Membrane Oxygenation ComplicationPlatelet Dysfunction IRCCS San Raffaele 50
Not applicableStudy completedNCT00669045What this trial is testingAn Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and 5 (POST)Who this might be right forAcute Myocardial Infarction Genentech, Inc. 253,668
Testing effectiveness (Phase 2)Study completedNCT00684203What this trial is testingTrial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)Who this might be right forAtherosclerosisMyocardial IschemiaMyocardial Infarction Merck Sharp & Dohme LLC 120
Large-scale testing (Phase 3)Looking for participantsNCT07714746What this trial is testingIvabradine in the Acute Management of Cardiogenic ShockWho this might be right forCardiogenic Shock Post Myocardial Infarction National Institute of Cardiovascular Diseases, Pakistan 200
Testing effectiveness (Phase 2)Study completedNCT00271765What this trial is testingINO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary InterventionWho this might be right forAcute Myocardial Infarction Inotek Pharmaceuticals Corporation 40
Large-scale testing (Phase 3)Study completedNCT02181985What this trial is testingFull Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)Who this might be right forMyocardial Infarction Boehringer Ingelheim 5,989
Testing effectiveness (Phase 2)Study completedNCT00677053What this trial is testingSafety and Efficacy of TAK-442 in Subjects With Acute Coronary SyndromesWho this might be right forAcute Coronary Syndrome Takeda 2,753
Testing effectiveness (Phase 2)Study completedNCT01324453What this trial is testingPhase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)Who this might be right forAcute Myocardial Infarction Minneapolis Heart Institute Foundation 103
Not applicableNot Yet RecruitingNCT07264881What this trial is testingFor Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.Who this might be right forMicrovascular Obstruction (MVO)Multivessel Coronary Artery DiseaseACS (Acute Coronary Syndrome)+1 more Beijing Anzhen Hospital 200